Qianting He

4PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 20, 2024
METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC.

Lianlian Liu, Tingting Zhao, Siyi Zheng

|May 15, 2023
SOX18 meditates the resistance of Bmi1-expressing cells to cetuximab in HNSCC.

Caihua Zhang, Zhi Chen, Nailin Gao

|Oct 13, 2022
SOD2 confers anlotinib resistance via regulation of mitochondrial damage in OSCC.

Shuai Li, Congyuan Cao, Zhexun Huang

Pageof 1